Literature DB >> 18728696

Synthesis and biological evaluation of (-)-dictyostatin and stereoisomers.

Youseung Shin1, Jean-Hugues Fournier, Arndt Brückner, Charitha Madiraju, Raghavan Balachandran, Brianne S Raccor, Michael C Edler, Ernest Hamel, Rachel P Sikorski, Andreas Vogt, Billy W Day, Dennis P Curran.   

Abstract

Total syntheses of (-)-dictyostatin, 6,16-bis-epi-dictyostatin, 6,14,19-tris-epi-dictyostatin and a number of other isomers and analogs are reported. Three main fragments-top, middle and bottom-were first assembled and then joined by olefination or anionic addition reactions. After appending the two dienes at either end of the molecule, macrolactonization and deprotection completed the syntheses. The work proves both the relative and absolute configurations of (-)-dictyostatin. The compounds were evaluated by cell-based measurements of increased microtubule mass and antiproliferative activity, and in vitro tubulin polymerization assays as well as competitive assays with paclitaxel for its binding site on microtubules. These assays showed dictyostatin to be the most potent of the agents and further showed that the structural alterations caused from 20- to >1000-fold decreases in activity.

Entities:  

Year:  2007        PMID: 18728696      PMCID: PMC2000856          DOI: 10.1016/j.tet.2007.05.033

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  35 in total

1.  The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site.

Authors:  E Hamel; D L Sackett; D Vourloumis; K C Nicolaou
Journal:  Biochemistry       Date:  1999-04-27       Impact factor: 3.162

2.  Total synthesis of (-)-dictyostatin.

Authors:  Gregory W O'Neil; Andrew J Phillips
Journal:  J Am Chem Soc       Date:  2006-04-26       Impact factor: 15.419

3.  Total synthesis of potential antitumor agent, (-)-dictyostatin.

Authors:  P Veeraraghavan Ramachandran; Amit Srivastava; Debasis Hazra
Journal:  Org Lett       Date:  2007-01-04       Impact factor: 6.005

4.  Chemistry. The renaissance of natural products as drug candidates.

Authors:  Ian Paterson; Edward A Anderson
Journal:  Science       Date:  2005-10-21       Impact factor: 47.728

5.  Design, synthesis and biological evaluation of a macrocyclic discodermolide/dictyostatin hybrid.

Authors:  Ian Paterson; Nicola M Gardner
Journal:  Chem Commun (Camb)       Date:  2006-11-23       Impact factor: 6.222

6.  Synthesis and biological evaluation of (-)-16-normethyldictyostatin: a potent analogue of (-)-dictyostatin.

Authors:  Youseung Shin; Jean-Hugues Fournier; Raghavan Balachandran; Charitha Madiraju; Brianne S Raccor; Guangyu Zhu; Michael C Edler; Ernest Hamel; Billy W Day; Dennis P Curran
Journal:  Org Lett       Date:  2005-07-07       Impact factor: 6.005

7.  Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural product.

Authors:  Peter Wipf; Thomas H Graham; Andreas Vogt; Rachel P Sikorski; Alexander P Ducruet; John S Lazo
Journal:  Chem Biol Drug Des       Date:  2006-01       Impact factor: 2.817

8.  Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.

Authors:  Tina L Tinley; Deborah A Randall-Hlubek; Rachel M Leal; Evelyn M Jackson; James W Cessac; James C Quada; Thomas K Hemscheidt; Susan L Mooberry
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

9.  Chemoenzymatic synthesis of the C10-C23 segment of dictyostatin.

Authors:  Evgeny Prusov; Hartmut Röhm; Martin E Maier
Journal:  Org Lett       Date:  2006-03-16       Impact factor: 6.005

10.  Repeat motifs of tau bind to the insides of microtubules in the absence of taxol.

Authors:  Santwana Kar; Juan Fan; Michael J Smith; Michel Goedert; Linda A Amos
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

View more
  8 in total

Review 1.  Conformation-activity relationships of polyketide natural products.

Authors:  Erik M Larsen; Matthew R Wilson; Richard E Taylor
Journal:  Nat Prod Rep       Date:  2015-08       Impact factor: 13.423

2.  (+)-Sorangicin A: evolution of a viable synthetic strategy.

Authors:  Amos B Smith; Shuzhi Dong; Richard J Fox; Jehrod B Brenneman; John A Vanecko; Tomohiro Maegawa
Journal:  Tetrahedron       Date:  2011-12-23       Impact factor: 2.457

3.  Streamlined syntheses of (-)-dictyostatin, 16-desmethyl-25,26-dihydrodictyostatin, and 6-epi-16-desmethyl-25,26-dihydrodictyostatin.

Authors:  Wei Zhu; María Jiménez; Won-Hyuk Jung; Daniel P Camarco; Raghavan Balachandran; Andreas Vogt; Billy W Day; Dennis P Curran
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

4.  Improved synthesis of 6-epi-dictyostatin and antitumor efficacy in mice bearing MDA-MB231 human breast cancer xenografts.

Authors:  Julie L Eiseman; Lihua Bai; Won-Hyuk Jung; Gustavo Moura-Letts; Billy W Day; Dennis P Curran
Journal:  J Med Chem       Date:  2008-10-08       Impact factor: 7.446

5.  A "methyl extension" strategy for polyketide natural product linker site validation and its application to dictyostatin.

Authors:  Stephen Ho; Dan L Sackett; James L Leighton
Journal:  J Am Chem Soc       Date:  2015-11-03       Impact factor: 15.419

6.  A highly step-economical synthesis of dictyostatin.

Authors:  Stephen Ho; Cyril Bucher; James L Leighton
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-10       Impact factor: 15.336

7.  Efficient syntheses of 25,26-dihydrodictyostatin and 25,26-dihydro-6-epi-dictyostatin, two potent new microtubule-stabilizing agents.

Authors:  María Jiménez; Wei Zhu; Andreas Vogt; Billy W Day; Dennis P Curran
Journal:  Beilstein J Org Chem       Date:  2011-10-05       Impact factor: 2.883

Review 8.  Natural products from the Lithistida: a review of the literature since 2000.

Authors:  Priscilla L Winder; Shirley A Pomponi; Amy E Wright
Journal:  Mar Drugs       Date:  2011-12-15       Impact factor: 6.085

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.